The impact of omega-3 polyunsaturated fatty acids on primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials
Mohammadi MM, Mirjalili R, Faraji A
Published in European Journal of Clinical Pharmacology
Methodology
Systematic review and random-effects meta-analysis of randomized controlled trials of omega-3 polyunsaturated fatty acids for primary dysmenorrhea, with Cochrane risk-of-bias assessment.
Key Findings
Omega-3 PUFAs reduced primary dysmenorrhea severity (SMD = -1.075, 95% CI -1.871 to -0.279).
Conclusions
Omega-3 supplementation reduces menstrual pain severity, though effect estimates are imprecise.
Limitations
Wide confidence interval, small heterogeneous trials, and variable dose and duration.
Supplements Studied
The results of the meta-analysis showed that n-3 PUFAs reduce the severity of primary dysmenorrhea in women (SMD = -1.075, 95% CI: -1.871 to -0.279)
Outcomes Measured
The results of the meta-analysis showed that n-3 PUFAs reduce the severity of primary dysmenorrhea in women (SMD = -1.075, 95% CI: -1.871 to -0.279)
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Not reported
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.